Jeff Tangney

Current Rank: #1919 globally (, 2025)
400 Rank: #389 (2025)
Industry: Healthcare IT
Company: Doximity
Revenue (2024): $475.4 million
Ownership Stake: Over 28%
Physician Adoption: >80% of U.S. doctors
Previous Exit: Epocrates sold to Athenahealth for $293 million
Education: BS, University of Wisconsin Madison; MBA, Stanford GSB
Residence: Palo Alto, California
Age: 53
Marital Status: Married, 3 children

Age: 53
Source of Wealth: Healthcare IT, Self-Made
Self-Made Score: 9 (out of 10)
Residence: Palo Alto, California
Citizenship: United States
Marital Status: Married
Children: 3
Education: Bachelor of Science, University of Wisconsin Madison; Master of Business Administration, Stanford Graduate School of Business
Did You Know? Tangney’s first job was washing dishes at Pizza Hut. He launched his first company, Epocrates, from his Stanford dorm room — a testament to his entrepreneurial drive and ability to identify high-impact opportunities in underserved markets. His journey from dishwasher to billionaire CEO underscores the power of persistence, domain-specific problem-solving, and leveraging elite educational networks to build scalable technology businesses.

Jeff Tangney’s net worth is derived primarily from his ownership stake in Doximity, a professional networking and telehealth platform for physicians. As of the latest available data, Tangney owns over 28% of the company, which generated $475.4 million in revenue in 2024. While the company is publicly traded, the precise valuation of his stake fluctuates with market conditions, investor sentiment, and the company’s financial performance. Tangney’s wealth is not solely tied to Doximity; he previously exited Epocrates, a mobile medical reference application, which he took public in 2011 and later sold to Athenahealth for $293 million. That transaction likely provided him with substantial liquidity and capital to reinvest in subsequent ventures, including Doximity.

Net worth estimates for Tangney vary depending on the source and timing. In 2021, following Doximity’s IPO, reported his net worth at $2.8 billion, based on a 32.9% ownership stake at the time. Since then, his stake has reportedly decreased to over 28%, which may reflect dilution from secondary offerings, employee stock grants, or personal sales. Publicly traded companies like Doximity are valued based on market capitalization — the total value of all outstanding shares — which can change daily. Tangney’s personal wealth is therefore not static; it is sensitive to stock price movements, macroeconomic trends, regulatory developments in healthcare, and competitive pressures in the digital health space.

It is important to note that private valuations and public market valuations differ significantly. While Doximity’s revenue provides a baseline for its operational scale, its market capitalization reflects investor expectations for future growth, profitability, and market dominance. Tangney’s stake, while substantial, does not equate to immediate liquidity unless he sells shares — and even then, large sales can depress the stock price. Additionally, as a founder and executive, he may be subject to lock-up periods or insider trading restrictions that limit his ability to monetize his holdings freely. His net worth, as reported by and other outlets, is an estimate based on publicly available data and should be interpreted as a snapshot rather than a precise figure.

As of 2025, Tangney is ranked #389 on the 400 and #1045 among global billionaires. These rankings reflect not only his current net worth but also the relative wealth of other billionaires, which can shift due to market volatility, currency fluctuations, and changes in asset valuations. Tangney’s inclusion in these lists underscores his status as a self-made entrepreneur in the healthcare technology sector, a field that has seen significant investment and innovation over the past decade. His wealth is a product of multiple successful exits, strategic ownership stakes, and the ability to scale a niche platform into a dominant industry player.

Jeff Tangney’s wealth trajectory is a case study in serial entrepreneurship within the healthcare technology sector. His first major financial milestone came with Epocrates, a mobile medical reference application he founded while attending Stanford Graduate School of Business. Launched from his dorm room, Epocrates became one of the earliest and most widely adopted digital tools for physicians, offering drug references, dosing calculators, and clinical guidelines. In 2011, Tangney took Epocrates public, a rare feat for a healthcare IT startup at the time. The IPO provided liquidity and visibility, and in 2013, he sold the company to Athenahealth for $293 million. This exit likely netted him tens of millions of dollars, providing the capital and credibility to launch his next venture.

In 2010, while Epocrates was still under his leadership, Tangney cofounded Doximity, a professional networking platform for physicians. The company was conceived as a “LinkedIn for Doctors,” aiming to connect medical professionals for collaboration, referrals, and career development. Unlike Epocrates, which was a utility tool, Doximity was designed as a social and professional network, leveraging the trust and verification of medical credentials. By 2024, Doximity had grown to include more than 80% of U.S. doctors as verified members, making it the de facto professional network for the medical community. The company’s revenue of $475.4 million in 2024 reflects its expansion into telehealth, advertising, and enterprise services for healthcare organizations.

Doximity’s IPO in 2021 marked Tangney’s second major liquidity event. At the time, he owned 32.9% of the company, which translated to a net worth of $2.8 billion according to . Since then, his stake has decreased to over 28%, which may indicate dilution from secondary offerings, employee stock grants, or personal sales. The company’s market capitalization has also fluctuated, influenced by broader market trends, investor sentiment toward digital health, and the company’s ability to monetize its user base. Tangney’s wealth has therefore evolved from a single exit (Epocrates) to a sustained, equity-based valuation tied to the ongoing performance of Doximity.

As of 2025, Tangney is ranked #389 on the 400 and #1045 among global billionaires. These rankings reflect not only his current net worth but also the relative wealth of other billionaires, which can shift due to market volatility, currency fluctuations, and changes in asset valuations. Tangney’s inclusion in these lists underscores his status as a self-made entrepreneur in the healthcare technology sector, a field that has seen significant investment and innovation over the past decade. His wealth is a product of multiple successful exits, strategic ownership stakes, and the ability to scale a niche platform into a dominant industry player.

Looking ahead, Tangney’s wealth will continue to be tied to Doximity’s performance. The company faces challenges common to digital health platforms, including regulatory scrutiny, competition from larger tech companies, and the need to monetize its user base without compromising trust. Tangney’s ability to navigate these challenges will determine whether his wealth continues to grow or stagnates. Additionally, as a founder and executive, he may choose to diversify his holdings, invest in other ventures, or philanthropic endeavors, which could further shape his financial trajectory. His wealth history is not just a record of financial gains but a reflection of his ability to identify unmet needs in healthcare, build scalable solutions, and execute exits that maximize value.

Jeff Tangney shares educational or professional ties with several notable figures. Anna Fang and Mary Barra both attended Stanford Graduate School of Business, suggesting a shared network of entrepreneurial and leadership training. Colin Huang, founder of Pinduoduo, shares an alma mater with Tangney — the University of Wisconsin Madison — indicating a common academic foundation in quantitative and analytical disciplines. Michele Kang, a healthcare IT investor and founder of Cognosante, represents a peer in the same sector, though her path is more focused on government contracting and health systems integration. These connections highlight Tangney’s positioning within elite educational and industry circles, which often facilitate access to capital, talent, and strategic partnerships.

Jeff Tangney’s early life and educational background laid the foundation for his entrepreneurial career in healthcare technology. Born in the United States, Tangney pursued higher education at the University of Wisconsin Madison, where he earned a Bachelor of Science degree. His academic focus during this period is not publicly disclosed in the provided data, but his later career suggests an interest in technology, business, or healthcare. After completing his undergraduate studies, Tangney enrolled at the Stanford Graduate School of Business, one of the most prestigious business schools in the world. It was during his time at Stanford that he launched his first company, Epocrates, from his dorm room — a testament to his entrepreneurial drive and ability to identify market opportunities even as a student.

Tangney’s first job was as a dishwasher at Pizza Hut, a humble beginning that contrasts sharply with his later success as a billionaire entrepreneur. This early work experience may have instilled in him a strong work ethic and an appreciation for the value of hard work, traits that are often cited by self-made entrepreneurs. His decision to pursue an MBA at Stanford indicates a strategic approach to his career, recognizing the value of formal business education in building and scaling companies. At Stanford, he was exposed to a network of like-minded entrepreneurs, investors, and industry leaders, which likely played a role in shaping his vision for Epocrates and later Doximity.

While specific details about his childhood, family background, or early influences are not provided in the data, Tangney’s educational and professional trajectory suggests a pattern of ambition, resourcefulness, and risk-taking. His ability to launch a successful startup while still in business school demonstrates an uncommon level of initiative and execution. The fact that he chose to focus on healthcare technology — a sector that requires deep domain knowledge and regulatory expertise — further underscores his willingness to tackle complex, high-stakes problems. His early life, though not extensively documented, appears to have been characterized by a combination of academic rigor, entrepreneurial spirit, and practical experience that prepared him for the challenges of building and scaling technology companies in the healthcare industry.

Jeff Tangney’s path to wealth is a textbook example of serial entrepreneurship in the healthcare technology sector. His journey began with Epocrates, a mobile medical reference application he founded while attending Stanford Graduate School of Business. Launched from his dorm room, Epocrates was one of the first digital tools designed specifically for physicians, offering drug references, dosing calculators, and clinical guidelines. The app quickly gained traction among medical professionals, who appreciated its convenience and reliability. In 2011, Tangney took Epocrates public, a rare achievement for a healthcare IT startup at the time. The IPO provided liquidity and visibility, and in 2013, he sold the company to Athenahealth for $293 million. This exit likely netted him tens of millions of dollars, providing the capital and credibility to launch his next venture.

In 2010, while Epocrates was still under his leadership, Tangney cofounded Doximity, a professional networking platform for physicians. The company was conceived as a “LinkedIn for Doctors,” aiming to connect medical professionals for collaboration, referrals, and career development. Unlike Epocrates, which was a utility tool, Doximity was designed as a social and professional network, leveraging the trust and verification of medical credentials. By 2024, Doximity had grown to include more than 80% of U.S. doctors as verified members, making it the de facto professional network for the medical community. The company’s revenue of $475.4 million in 2024 reflects its expansion into telehealth, advertising, and enterprise services for healthcare organizations.

Doximity’s IPO in 2021 marked Tangney’s second major liquidity event. At the time, he owned 32.9% of the company, which translated to a net worth of $2.8 billion according to . Since then, his stake has decreased to over 28%, which may indicate dilution from secondary offerings, employee stock grants, or personal sales. The company’s market capitalization has also fluctuated, influenced by broader market trends, investor sentiment toward digital health, and the company’s ability to monetize its user base. Tangney’s wealth has therefore evolved from a single exit (Epocrates) to a sustained, equity-based valuation tied to the ongoing performance of Doximity.

As of 2025, Tangney is ranked #389 on the 400 and #1045 among global billionaires. These rankings reflect not only his current net worth but also the relative wealth of other billionaires, which can shift due to market volatility, currency fluctuations, and changes in asset valuations. Tangney’s inclusion in these lists underscores his status as a self-made entrepreneur in the healthcare technology sector, a field that has seen significant investment and innovation over the past decade. His wealth is a product of multiple successful exits, strategic ownership stakes, and the ability to scale a niche platform into a dominant industry player.

Looking ahead, Tangney’s wealth will continue to be tied to Doximity’s performance. The company faces challenges common to digital health platforms, including regulatory scrutiny, competition from larger tech companies, and the need to monetize its user base without compromising trust. Tangney’s ability to navigate these challenges will determine whether his wealth continues to grow or stagnates. Additionally, as a founder and executive, he may choose to diversify his holdings, invest in other ventures, or philanthropic endeavors, which could further shape his financial trajectory. His path to wealth is not just a record of financial gains but a reflection of his ability to identify unmet needs in healthcare, build scalable solutions, and execute exits that maximize value.

Jeff Tangney’s empire centers on Doximity, a vertically integrated healthcare IT platform that has achieved near-monopoly status among U.S. physicians. With over 80% of American doctors as verified users, Doximity functions as both a professional network and a telehealth infrastructure, creating a self-reinforcing ecosystem. Unlike generalist platforms, its value proposition is deeply embedded in clinical workflows — from secure messaging to job placement and continuing education. This concentration of user base within a highly regulated, credential-dependent profession creates a formidable moat. However, it also introduces systemic risk: any erosion in trust, regulatory noncompliance, or technological disruption could trigger cascading churn. Tangney’s prior success with Epocrates — a mobile reference tool later sold for $293M — demonstrates his ability to identify and monetize niche healthcare needs. His empire is not built on scale alone, but on precision targeting of high-value, low-churn professional segments.

Tangney’s leadership is defined by operational pragmatism and stealth execution. As a non-physician leading a physician-centric platform, he has relied on deep domain partnerships and product-led growth rather than charismatic authority. His background — from Pizza Hut dishwasher to Stanford MBA founder — suggests a resilience and adaptability uncommon in tech elites. He avoids public spectacle, focusing instead on metrics-driven expansion and regulatory navigation. This low-profile, high-efficiency style has allowed Doximity to scale without attracting the scrutiny faced by consumer-facing platforms. However, it also risks underestimating the need for public-facing brand stewardship as the company expands into telehealth and data monetization — areas where perception and trust are as critical as functionality.

Tangney’s capital allocation strategy reflects a disciplined, founder-led approach. After exiting Epocrates, he reinvested proceeds into Doximity, maintaining over 28% ownership despite the company’s $475M+ revenue. This signals long-term alignment with shareholder value and resistance to premature dilution. Capital has been directed toward product integration — embedding telehealth, credential verification, and job matching — rather than aggressive M&A or global expansion. The focus remains on deepening engagement within the U.S. physician cohort, a high-margin, low-churn demographic. However, this concentration poses a risk: over-reliance on a single professional segment limits diversification. Future capital deployment must balance vertical expansion (e.g., into nursing or allied health) with geographic scaling, particularly in markets with similar regulatory frameworks.

Doximity’s dominance invites regulatory and reputational risks. As a platform handling sensitive clinical data and professional communications, it faces intense scrutiny under HIPAA and state privacy laws. Any breach or misuse of physician data could trigger litigation, fines, or loss of trust. The company’s near-monopoly among U.S. doctors also raises antitrust concerns, particularly as it integrates telehealth and job placement — functions that could be seen as gatekeeping access to professional opportunities. Tangney’s non-clinical background may also be leveraged by critics to question the platform’s medical legitimacy. Geopolitically, reliance on U.S.-centric infrastructure and regulation limits global scalability, exposing the business to domestic policy shifts. Reputationally, any perceived exploitation of physician data for advertising or recruitment could alienate its core user base.

While Tangney’s philanthropic activities are not widely publicized, his background suggests a preference for impact-driven, under-the-radar giving. His journey from dishwasher to billionaire implies a personal commitment to upward mobility, potentially translating into support for education or healthcare access initiatives. Given his Stanford MBA and Wisconsin roots, he may favor institutions that foster entrepreneurship or STEM education in underserved communities. However, without public disclosures, his philanthropy remains speculative. In an era where tech leaders face pressure to demonstrate social responsibility, Tangney’s lack of visible giving could become a reputational liability — particularly if Doximity’s data practices draw criticism. Strategic, transparent philanthropy could serve as a counterbalance to regulatory and ethical concerns.

Tangney’s political influence is indirect but potent. Through Doximity’s control of physician communication channels, he wields soft power over medical opinion and policy adoption. The platform’s role in disseminating clinical guidelines, job opportunities, and telehealth tools positions it as a de facto infrastructure for healthcare delivery — a role that intersects with federal and state health policy. While Tangney himself avoids overt political engagement, his company’s data and network could be leveraged by policymakers or advocacy groups. Regulatory changes — such as those affecting telehealth reimbursement or data privacy — directly impact Doximity’s valuation, making political risk a core component of its business model. Tangney’s Palo Alto base and Stanford ties also connect him to elite tech and policy circles, though he has not yet emerged as a public policy voice.

Tangney’s legacy will be defined by his ability to transform physician networking from a fragmented, analog process into a secure, digital ecosystem. If Doximity maintains its dominance and expands into adjacent healthcare services, he will be remembered as a quiet architect of medical infrastructure — akin to the builders of enterprise software that underpin modern industries. His non-clinical background may be viewed as a strength: proof that deep domain understanding can be achieved through partnership and product design, not professional credentials. However, his legacy is vulnerable to regulatory backlash or technological disruption. If Doximity fails to adapt to AI-driven clinical tools or global healthcare shifts, his empire may be seen as a niche success rather than a transformative force. His true legacy may lie in proving that healthcare IT can be both profitable and mission-driven — if governance and ethics keep pace with growth.

• Profile: Jeff Tangney —
• 400 & Billionaires Lists (2025) —
• Stanford Graduate School of Business Alumni Network
• University of Wisconsin Madison Alumni Database